ResearcherMinzu University of ChinaNo recent work listed

Yong Cheng Ma

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-7529-4408; OpenAlex author ID A5052627018. Sources: OpenAlex.

Their work

Papers: 3 (first author 0, last author 3)
Trials: 0
Grants: 0
Labs led: 1
Collaborators: 3

Papers, trials and grants by year

2020: 3 papers

Papers 3

The USP22 promotes the growth of cancer cells through the DYRK1A in pancreatic ductal adenocarcinoma. Last author DOI 10.1016/j.gene.2020.144960 ↗
Citron Rho-Interacting Serine/Threonine Kinase Promotes HIF1a-CypA Signaling and Growth of Human Pancreatic Adenocarcinoma. Last author DOI 10.1155/2020/9210891 ↗
Carboxypeptidase E down-regulation regulates transcriptional and epigenetic profiles in pancreatic cancer cell line: A network analysis. Last author DOI 10.3233/cbm-191163 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Zhile Bai · 3 shared papers, 2020 · strength 0.47
Cong Lin · 2 shared papers, 2020 · strength 0.32
- Paper The USP22 promotes the growth of cancer cells through the DYRK1A in pancreatic ductal adenocarcinoma. DOI 10.1016/j.gene.2020.144960 ↗
- Paper Citron Rho-Interacting Serine/Threonine Kinase Promotes HIF1a-CypA Signaling and Growth of Human Pancreatic Adenocarcin… DOI 10.1155/2020/9210891 ↗
Mengyu Feng · 1 shared paper, 2020 · strength 0.15
- Paper Carboxypeptidase E down-regulation regulates transcriptional and epigenetic profiles in pancreatic cancer cell line: A … DOI 10.3233/cbm-191163 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.